FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Siegfried Kasper

Research Profile

Concepts & Ideas

Disorders

Chemicals & Drugs

Procedures

Geographic Areas

Austria

Anatomy

Brain

Co-author Network

Publications

TOP 3
Andreas Hahn; Georgios Karanikas; Siegfried Kasper; Christoph Kraus; Pia Baldinger; Wolfgang Birkfellner; Richard Frey; Daniela Haeusler; Markus Mitterhauser; Lukas Nics; Markus Savli; Johanna Ungersboeck; Wolfgang Wadsak; Rupert Lanzenberger
Application of image-derived and venous input functions in major depression using [carbonyl-(11)C]WAY-100635.
Markus Dold; Martin Aigner; Rupert Lanzenberger; Siegfried Kasper
Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.
Peter Höfer; Rupert Lanzenberger; Siegfried Kasper
Testosterone in the brain: neuroimaging findings and the potential role for neuropsychopharmacology.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Siegfried Kasper (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andreas Hahn; Georgios Karanikas; Siegfried Kasper; Christoph Kraus; Pia Baldinger; Wolfgang Birkfellner; Richard Frey; Daniela Haeusler; Markus Mitterhauser; Lukas Nics; Markus Savli; Johanna Ungersboeck; Wolfgang Wadsak; Rupert Lanzenberger
Application of image-derived and venous input functions in major depression using [carbonyl-(11)C]WAY-100635.
Nuclear medicine and biology 2013;40(3):371-7.
2013: Markus Dold; Martin Aigner; Rupert Lanzenberger; Siegfried Kasper
Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2013;16(3):557-74.
2013: Peter Höfer; Rupert Lanzenberger; Siegfried Kasper
Testosterone in the brain: neuroimaging findings and the potential role for neuropsychopharmacology.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2013;23(2):79-88.
2013: Rupert Lanzenberger; Z Micskei; Markus Mitterhauser; P Stein; J Ungersboeck; Wolfgang Wadsak; D Winkler; P Baldinger; A Hahn; Georgios Karanikas; Siegfried Kasper; R Frey
Impact of electroconvulsive therapy on 5-HT1A receptor binding in major depression.
Molecular psychiatry 2013;18(1):1.
2013: Rupert Lanzenberger; Z Micskei; Markus Mitterhauser; P Stein; J Ungersboeck; Wolfgang Wadsak; D Winkler; P Baldinger; A Hahn; Georgios Karanikas; Siegfried Kasper; R Frey
Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.
Molecular psychiatry 2013;18(1):93-100.
2012: Christoph Kraus; Pia Baldinger; Daniela Haeusler; Andreas Hahn; Anna Höflich; Siegfried Kasper; Georg S Kranz; Markus Mitterhauser; Markus Savli; Christoph Spindelegger; Johanna Ungersboeck; Wolfgang Wadsak; Christian Windischberger; Rupert Lanzenberger
Serotonin-1A receptor binding is positively associated with gray matter volume -- a multimodal neuroimaging study combining PET and structural MRI.
NeuroImage 2012;63(3):1091-8.
2012: Rupert Lanzenberger; Markus Mitterhauser; Cecile Philippe; Markus Savli; Christoph Spindelegger; Wolfgang Wadsak; Elena Akimova; Martin Fink; Daniela Haeusler; Andreas Hahn; Georgios Karanikas; Georg S Kranz; Siegfried Kasper
Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.
NeuroImage 2012;63(2):874-81.
2012: Markus Savli; Johanna Ungersboeck; Wolfgang Wadsak; Markus Mitterhauser; Alexander Neumeister; Frank Rattay; Andreas Bauer; Yu-Shin Ding; Daniela Haeusler; Andreas Hahn; Shannan Henry; Sanaz Attaripour Isfahani; Siegfried Kasper; Tina Kroll; Rupert Lanzenberger
Normative database of the serotonergic system in healthy subjects using multi-tracer PET.
NeuroImage 2012;63(1):447-59.
2012: Reinhard Fischer; Siegfried Kasper; Edda Pjrek; Dietmar Winkler
On the application of light therapy in German-speaking countries.
European archives of psychiatry and clinical neuroscience 2012;262(6):501-5.
2012: Siegfried Kasper
Clinical data in early intervention.
International psychogeriatrics / IPA 2012;24 Suppl 1():S41-5.
2012: Andreas Hahn; Georgios Karanikas; Siegfried Kasper; Pia Baldinger; Wolfgang Birkfellner; Peter Dolliner; Richard Frey; Markus Mitterhauser; Lukas Nics; Johanna Ungersböck; Wolfgang Wadsak; Rupert Lanzenberger
Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling.
NeuroImage 2012;62(1):199-206.
2012: Roland N Boubela; Peter Filzmoser; Wolfgang Huf; Klaudius Kalcher; Siegfried Kasper; Lukas Pezawas; Ronald Sladky; Christian Windischberger; Ewald Moser
A highly parallelized framework for computationally intensive MR data analysis.
Magma (New York, N.Y.) 2012;25(4):313-20.
2012: Alexandra Schosser; Alessandro Serretti; Daniel Souery; Joseph Zohar; Julien Mendlewicz; Stuart Montgomery; Siegfried Kasper
European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2012;22(7):453-68.
2012: Siegfried Kasper; Klaus Larsen; Bjarke Ebert; Brigitte Tonnoir
Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012;15(6):715-25.
2012: Benjamin Vyssoki; Matthäus Willeit; Victor Blüml; Siegfried Kasper; Nicole Praschak-Rieder; Gernot Sonneck; Nestor D. Kapusta
Effects of sunshine on suicide rates.
Comprehensive psychiatry 2012;53(5):535-9.
2012: Martin Letmaier; Annamaria Painold; Hartmut Vergin; Rolf Engel; Anna Katharina Holl; Siegfried Kasper; Anastasios Konstantinidis; Renate Grohmann
Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012;15(6):739-48.
2012: A Konstantinidis; K Papageorgiou; R Engel; R Grohmann; A Horvath; Siegfried Kasper
Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012;15(4):449-57.
2012: A Naderi-Heiden; H Nassan-Agha; C Bäcker; D Bieber; Andreas Gleiss; Siegfried Kasper; Richard Frey
Mortality and employment after in-patient opiate detoxification.
European psychiatry : the journal of the Association of European Psychiatrists 2012;27(4):294-300.
2012: A Schosser; A Serretti; Daniel Souery; J Zohar; N A Kocabas; Sylvie Linotte; Isabelle Massat; J Mendlewicz; Stuart Montgomery; K Papageorgiou; Raffaella Calati; A Juven-Wetzler; Siegfried Kasper
The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2012;22(4):259-66.
2012: Andreas Hahn; Anna S Höflich; Georgios Karanikas; Siegfried Kasper; Georg S Kranz; Christoph Kraus; Jan Losak; Markus Mitterhauser; Lukas Nics; Cécile Philippe; Wolfgang Wadsak; Christian Windischberger; Pia Baldinger; Rupert Lanzenberger
Differential modulation of the default mode network via serotonin-1A receptors.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(7):2619-24.
2012: Hans-Jürgen Möller; I Bitter; J Bobes; K Fountoulakis; C Höschl; Siegfried Kasper
Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression.
European psychiatry : the journal of the Association of European Psychiatrists 2012;27(2):114-28.
2012: Thomas C Baghai; David S Baldwin; Michael Bauer; Pierre Blier; Kostas N Fountoulakis; Guy M Goodwin; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.
European archives of psychiatry and clinical neuroscience 2012;262(1):13-22.
2012: Martin Bauer; Siegfried Kasper; Nicole Praschak-Rieder; Matthaus Willeit
Is dopamine neurotransmission altered in prodromal schizophrenia? A review of the evidence.
Current pharmaceutical design 2012;18(12):1568-79.
2011: Christian Scharinger; Lukas Pezawas; Ulrich Rabl; Siegfried Kasper
The genetic blueprint of major depressive disorder: contributions of imaging genetics studies.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2011;12(7):474-88.
2011: Martin Aigner; Siegfried Kasper; Walter Kaye; Janet Treasure
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2011;12(6):400-43.
2011: Andreas Hahn; Patrycja Stein; Christian Windischberger; Andreas Weissenbacher; Christoph Spindelegger; Ewald Moser; Siegfried Kasper; Rupert Lanzenberger
Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder.
NeuroImage 2011;56(3):881-9.
2011: Jochen Kindler; Ursula Bailer; Martina de Zwaan; Karoline Fuchs; Franz Leisch; Bettina Grün; Alexandra Strnad; Mirjana Stojanovic; Julia Windisch; Claudia Lennkh-Wolfsberg; Nadja El-Giamal; Werner Sieghart; Siegfried Kasper; Harald N Aschauer
No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with eating disorders.
Nordic journal of psychiatry 2011;65(3):203-7.
2011: Dietmar Winkler; A Naderi-Heiden; A Strnad; Edda Pjrek; J Scharfetter; Siegfried Kasper; Richard Frey
Intensive care in psychiatry.
European psychiatry : the journal of the Association of European Psychiatrists 2011;26(4):260-4.
2011: Michael Soyka; Henry R Kranzler; Wim van den Brink; John Krystal; Hans-Jürgen Möller; Siegfried Kasper
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2011;12(3):160-87.
2011: Wolfgang Huf; Klaudius Kalcher; Gerald Pail; Michaela-Elena Friedrich; Peter Filzmoser; Siegfried Kasper
Meta-analysis: fact or fiction? How to interpret meta-analyses.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2011;12(3):188-200.
2011: Anastasios Konstantinidis; Klaus Martiny; Per Bech; Siegfried Kasper
A comparison of the Major Depression Inventory (MDI) and the Beck Depression Inventory (BDI) in severely depressed patients.
International journal of psychiatry in clinical practice 2011;15(1):56-61.
2011: Susanne Monika Bauer; Hans Steiner; Martha Feucht; Thomas Stompe; Niranjan S Karnik; Siegfried Kasper; Belinda Plattner
Psychosocial background in incarcerated adolescents from Austria, Turkey and former Yugoslavia.
Psychiatry research 2011;185(1-2):193-9.
2011: Luiza Olajossy-Hilkesberger; Alexandra Schosser-Haupt; Jacek Wojcierowski; Beata Godlewska; Jerzy Landowski; Halina Marmurowska-Michałowska; Marcin Olajossy; Siegfried Kasper
Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia.
Neuropsychobiology 2011;64(4):202-10.
2011: Gerald Pail; Edda Pjrek; Nicole Praschak-Rieder; Matthäus Willeit; Dietmar Winkler; Wolfgang Huf; Siegfried Kasper
Bright-light therapy in the treatment of mood disorders.
Neuropsychobiology 2011;64(3):152-62.
2011: Siegfried Kasper; Diana Meshkat; Alexandra Kutzelnigg
Improvement of the noradrenergic symptom cluster following treatment with milnacipran.
Neuropsychiatric disease and treatment 2011;7(Suppl 1):21-7.
2011: Rupert Lanzenberger; Markus Mitterhauser; Ulrike Moser; Markus Savli; Christoph Spindelegger; Patrycja Stein; Wolfgang Wadsak; Kurt Kletter; Georg S Kranz; Siegfried Kasper
Progesterone level predicts serotonin-1a receptor binding in the male human brain.
Neuroendocrinology 2011;94(1):84-8.
2010: Siegfried Kasper; Markus Gastpar; Walter E Müller; Hans-Peter Volz; Hans-Jürgen Möller; Angelika Dienel; Sandra Schläfke
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.
Wiener medizinische Wochenschrift (1946) 2010;160(21-22):547-56.
2010: Siegfried Kasper; Filippo Caraci; Bruno Forti; Filippo Drago; Eugenio Aguglia
Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010;20(11):747-65.
2010: Andreas Hahn; Rupert Lanzenberger; Wolfgang Wadsak; Christoph Spindelegger; Uirike Moser; Leonhard-Key Mien; Markus Mitterhauser; Siegfried Kasper
Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(43):14482-9.
2010: Rupert Lanzenberger; Wolfgang Wadsak; Christoph Spindelegger; Markus Mitterhauser; Elena Akimova; Leonhard-Key Mien; Martin Fink; Ulrike Moser; Markus Savli; Georg S Kranz; Andreas Hahn; Kurt Kletter; Siegfried Kasper
Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010;13(9):1129-43.
2010: Siegfried Kasper; Markus Gastpar; Hans-Juergen Möller; Walter E Müller; Hans-Peter Volz; Angelika Dienel; Meinhard Kieser
Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression.
International clinical psychopharmacology 2010;25(4):204-13.
2010: Ulrike Moser; Wolfgang Wadsak; Christoph Spindelegger; Markus Mitterhauser; Leonhard-Key Mien; Christian Bieglmayer; Kurt Kletter; Siegfried Kasper; Rupert Lanzenberger
Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women.
Neuroscience letters 2010;476(3):161-5.
2010: A Naderi-Heiden; A Naderi; M M Naderi; F Rahmani-Didar; A-R Salimi; Andreas Gleiss; Siegfried Kasper; Richard Frey
Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran.
Pharmacopsychiatry 2010;43(4):130-7.
2010: Alexandra Schosser; Karoline Fuchs; theresa scharl; Monika Schloegelhofer; Jochen Kindler; Nilufar Mossaheb; Rainer M Kaufmann; Friedrich Leisch; Siegfried Kasper; Werner Sieghart; Harald N Aschauer
Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(2 Pt 2):417-24.
2010: Siegfried Kasper; Göran Hajak; Katharina Wulff; Witte J G Hoogendijk; Angel Luis Montejo; Enrico Smeraldi; Janusz K Rybakowski; Maria-Antonia Quera-Salva; Anna M Wirz-Justice; Françoise Picarel-Blanchot; Franck J Baylé
Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
The Journal of clinical psychiatry 2010;71(2):109-20.
2010: Siegfried Kasper; Stuart A Montgomery; Hans-Jürgen Möller; Helga J J van Oers; Albert Jan Schutte; Peter Vrijland; Egbert A van der Meulen
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(1):36-44.
2010: Siegfried Kasper; Hans-Jürgen Möller; Anthony Hale
The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatment.
European archives of psychiatry and clinical neuroscience 2010;260(1):59-68.
2010: Christian Windischberger; Rupert Lanzenberger; Alexander Holik; Christoph Spindelegger; Patrycja Stein; Ulrike Moser; Florian Gerstl; Martin Fink; Ewald Moser; Siegfried Kasper
Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.
NeuroImage 2010;49(2):1161-70.
2010: A Veronica Witte; Markus Savli; Alexander Holik; Siegfried Kasper; Rupert Lanzenberger
Regional sex differences in grey matter volume are associated with sex hormones in the young adult human brain.
NeuroImage 2010;49(2):1205-12.
2010: Siegfried Kasper; Gerald Pail
Milnacipran: a unique antidepressant?
Neuropsychiatric disease and treatment 2010;6():23-31.
2010: R M Kaufmann; B Kraft; R Frey; Dietmar Winkler; S Weiszenbichler; C Bäcker; Siegfried Kasper; H G Kress
Acute psychotropic effects of oral cannabis extract with a defined content of Delta9-tetrahydrocannabinol (THC) in healthy volunteers.
Pharmacopsychiatry 2010;43(1):24-32.
2009: Martin Fink; Elena Akimova; Christoph Spindelegger; Andreas Hahn; Rupert Lanzenberger; Siegfried Kasper
Social anxiety disorder: epidemiology, biology and treatment.
Psychiatria Danubina 2009;21(4):533-42.
2009: Christoph Spindelegger; Rupert Lanzenberger; Wolfgang Wadsak; Leonhard-Key Mien; P Stein; Markus Mitterhauser; U Moser; Alexander Holik; Lukas Pezawas; Kurt Kletter; Siegfried Kasper
Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders.
Molecular psychiatry 2009;14(11):1040-50.
2009: Elena Akimova; Rupert Lanzenberger; Siegfried Kasper
The serotonin-1A receptor in anxiety disorders.
Biological psychiatry 2009;66(7):627-35.
2009: Belinda Plattner; Hans Steiner; Steve S L The; Helena C Kraemer; Susanne M Bauer; Jochen Kindler; Max H Friedrich; Siegfried Kasper; Martha Feucht
Sex-specific predictors of criminal recidivism in a representative sample of incarcerated youth.
Comprehensive psychiatry 2009;50(5):400-7.
2009: Siegfried Kasper; H Schubert
[Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
Fortschritte der Neurologie-Psychiatrie 2009;77(9):494-506.
2009: A Veronica Witte; Agnes Flöel; Patrycja Stein; Markus Savli; Leonhard-Key Mien; Wolfgang Wadsak; Christoph Spindelegger; Ulrike Moser; Martin Fink; Andreas Hahn; Markus Mitterhauser; Kurt Kletter; Siegfried Kasper; Rupert Lanzenberger
Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects.
Human brain mapping 2009;30(8):2558-70.
2009: Siegfried Kasper
The psychiatrist confronted with a fibromyalgia patient.
Human psychopharmacology 2009;24 Suppl 1():S25-30.
2009: Michaela-Elena Seyringer; Siegfried Kasper
Ranking antidepressants.
Lancet 2009;373(9677):1760-1; author reply 1761-2.
2009: Siegfried Kasper; Julia Sacher; Nikolas Klein; Nilufar Mossaheb; Trawat Attarbaschi-Steiner; Rupert Lanzenberger; Christoph Spindelegger; Susanne Asenbaum; Alexander Holik; Robert Dudczak
Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram.
International clinical psychopharmacology 2009;24(3):119-25.
2009: Edda Pjrek; Anastasios Konstantinidis; Eva Assem-Hilger; Nicole Praschak-Rieder; Matthäus Willeit; Siegfried Kasper; Dietmar Winkler
Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis.
Journal of psychiatric research 2009;43(8):792-7.
2009: Siegfried Kasper; David S Baldwin; Sara Larsson Lönn; Jean-Philippe Boulenger
Superiority of escitalopram to paroxetine in the treatment of depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(4):229-37.
2009: Martin Fink; Wolfgang Wadsak; Markus Savli; Patrycja Stein; Ulrike Moser; Andreas Hahn; Leonhard-Key Mien; Kurt Kletter; Markus Mitterhauser; Siegfried Kasper; Rupert Lanzenberger
Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET.
NeuroImage 2009;45(2):598-605.
2009: Siegfried Kasper; Barry Herman; Giancarlo Nivoli; Michael Van Ameringen; Antonino Petralia; Francine S Mandel; Francesca Baldinetti; Borwin Bandelow
Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial.
International clinical psychopharmacology 2009;24(2):87-96.
2009: Angela Naderi-Heiden; Shahin Shadnia; Ali-Reza Salimi; Ahmad Naderi; Mohammad M Naderi; Daniela Schmid; Andreas Gleiss; Siegfried Kasper; Richard Frey
Self-poisonings with tricyclic antidepressants and selective serotonin reuptake inhibitors in Tehran, Iran.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4):302-12.
2009: Siegfried Kasper; Dietmar Winkler; Alexandra Kutzelnigg
[Significance of Ginkgo biloba extract in dementia].
Pharmazie in unserer Zeit 2009;38(5):424-30.
2009: Siegfried Kasper; Michel Hamon
Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(2):117-26.
2008: Siegfried Kasper; Hans-Peter Volz; H J Möller; Angelika Dienel; Meinhard Kieser
Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(11):803-13.
2008: Siegfried Kasper
Do we need another atypical antipsychotic?
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18 Suppl 3():S146-52.
2008: F Grass; Siegfried Kasper
Humoral phototransduction: light transportation in the blood, and possible biological effects.
Medical hypotheses 2008;71(2):314-7.
2008: Siegfried Kasper
Everyday problems in treating depression: focus on SNRIs. Introduction.
CNS spectrums 2008;13(7 Suppl 11):4.
2008: Florian Gerstl; Christian Windischberger; Markus Mitterhauser; Wolfgang Wadsak; Alexander Holik; Kurt Kletter; Ewald Moser; Siegfried Kasper; Rupert Lanzenberger
Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET.
NeuroImage 2008;41(2):204-11.
2008: Matthäus Willeit; Harald H Sitte; Nikolaus Thierry; Klaus Michalek; Nicole Praschak-Rieder; Peter Zill; Dietmar Winkler; Werner Brannath; Michael B Fischer; Brigitta Bondy; Siegfried Kasper; Ernst A Singer
Enhanced serotonin transporter function during depression in seasonal affective disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(7):1503-13.
2008: Julia Sacher; Nilufar Mossaheb; Christoph Spindelegger; Nikolas Klein; Thomas Geiss-Granadia; Robert Sauermann; Edith Lackner; Christian Joukhadar; Markus Müller; Siegfried Kasper
Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(7):1633-41.
2008: Edda Pjrek; Matthäus Willeit; Nicole Praschak-Rieder; Anastasios Konstantinidis; Heribert V Semlitsch; Siegfried Kasper; Dietmar Winkler
Treatment of seasonal affective disorder with duloxetine: an open-label study.
Pharmacopsychiatry 2008;41(3):100-5.
2008: Siegfried Kasper; M Gastpar; W E Müller; Hans-Peter Volz; Angelika Dienel; Meinhard Kieser; Hans-Jürgen Möller
Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials.
European archives of psychiatry and clinical neuroscience 2008;258(1):59-63.
2008: Siegfried Kasper; Bruce McEwen
Neurobiological and clinical effects of the antidepressant tianeptine.
CNS drugs 2008;22(1):15-26.
2007: Stuart A Montgomery; David S Baldwin; Pierre Blier; Naomi A Fineberg; Siegfried Kasper; Malcolm Lader; Raymond Lam; Jean-Pierre Lépine; Hans-Jürgen Möller; David J Nutt; Frederic Rouillon; Alan F Schatzberg; Michael E Thase
Which antidepressants have demonstrated superior efficacy? A review of the evidence.
International clinical psychopharmacology 2007;22(6):323-9.
2007: Edda Pjrek; Dietmar Winkler; Nicole Praschak-Rieder; Matthäus Willeit; Jürgen Stastny; Anastasios Konstantinidis; Siegfried Kasper
Season of birth in siblings of patients with seasonal affective disorder. A test of the parental conception habits hypothesis.
European archives of psychiatry and clinical neuroscience 2007;257(7):378-82.
2007: Stuart A Montgomery; Siegfried Kasper
Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine.
International clinical psychopharmacology 2007;22(5):283-91.
2007: Dietmar Winkler; Edda Pjrek; Ulrike Moser; Siegfried Kasper
Escitalopram in a working population: results from an observational study of 2378 outpatients in Austria.
Human psychopharmacology 2007;22(4):245-51.
2007: Edda Pjrek; Dietmar Winkler; David W Abramson; Anastasios Konstantinidis; Jürgen Stastny; Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Serum lipid levels in seasonal affective disorder.
European archives of psychiatry and clinical neuroscience 2007;257(4):197-202.
2007: Alexandra Schosser; Karoline Fuchs; theresa scharl; Franz Leisch; Ursula Bailer; Siegfried Kasper; Werner Sieghart; Kurt Hornik; Harald N Aschauer
Additional support for linkage of schizophrenia and bipolar disorder to chromosome 3q29.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(6-7):501-5.
2007: Rupert Lanzenberger; Markus Mitterhauser; Christoph Spindelegger; Wolfgang Wadsak; Nikolas Klein; Leonhard-Key Mien; Alexander Holik; Trawat Attarbaschi; Nilufar Mossaheb; Julia Sacher; Thomas Geiss-Granadia; Kurt Kletter; Siegfried Kasper; Johannes Tauscher
Reduced serotonin-1A receptor binding in social anxiety disorder.
Biological psychiatry 2007;61(9):1081-9.
2007: Nikolas Klein; Julia Sacher; Thomas Geiss-Granadia; Nilufar Mossaheb; Trawat Attarbaschi; Rupert Lanzenberger; Christoph Spindelegger; Alexander Holik; Susanne Asenbaum; Robert Dudczak; Johannes Tauscher; Siegfried Kasper
Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
Psychopharmacology 2007;191(2):333-9.
2007: Julia Sacher; Susanne Asenbaum; Nikolas Klein; Thomas Geiss-Granadia; Nilufar Mossaheb; Christian Poetzi; Trawat Attarbaschi; Rupert Lanzenberger; Christoph Spindelegger; Alexander Rabas; Georg Heinze; Robert Dudczak; Siegfried Kasper; Johannes Tauscher
Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(2):211-8.
2007: Edda Pjrek; Dietmar Winkler; Anastasios Konstantinidis; Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Agomelatine in the treatment of seasonal affective disorder.
Psychopharmacology 2007;190(4):575-9.
2007: Anastasios Konstantinidis; Wolfgang Hrubos; G Nirnberger; E Windhager; M Lehofer; Harald N Aschauer; Siegfried Kasper
Quetiapine in combination with citalopram in patients with unipolar psychotic depression.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(1):242-7.
2007: Trawat Attarbaschi; Julia Sacher; Thomas Geiss-Granadia; Nikolas Klein; Nilufar Mossaheb; Rupert Lanzenberger; Susanne Asenbaum; Robert Dudczak; Siegfried Kasper; Johannes Tauscher
Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(2):102-7.
2007: Siegfried Kasper; Ion Anghelescu; Armin Szegedi; Angelika Dienel; Meinhard Kieser
Placebo controlled continuation treatment with Hypericum extract WS 5570 after recovery from a mild or moderate depressive episode.
Wiener medizinische Wochenschrift (1946) 2007;157(13-14):362-6.
2007: Edda Pjrek; Dietmar Winkler; Jürgen Stastny; Nicole Praschak-Rieder; Matthäus Willeit; Siegfried Kasper
Escitalopram in seasonal affective disorder: results of an open trial.
Pharmacopsychiatry 2007;40(1):20-4.
2006: Trawat Attarbaschi; Siegfried Kasper
[Treatment options for bipolar mania].
Der Nervenarzt 2006;77(11):1310-4, 1317-8, 1320-2.
2006: Nikolas Klein; Julia Sacher; Thomas Geiss-Granadia; Trawat Attarbaschi; Nilufar Mossaheb; Rupert Lanzenberger; Christian Pötzi; Alexander Holik; Christoph Spindelegger; Susanne Asenbaum; Robert Dudczak; Johannes Tauscher; Siegfried Kasper
In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
Psychopharmacology 2006;188(3):263-72.
2006: Martin Letmaier; Daniel Schreinzer; Lutz Reinfried; Georg Glauninger; Nikolaus Thierry; Thomas Kapitany; Siegfried Kasper
Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural setting.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(5):529-37.
2006: Siegfried Kasper
Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2006;16 Suppl 3():S135-41.
2006: Dietmar Winkler; Edda Pjrek; Rie Iwaki; Siegfried Kasper
Treatment of seasonal affective disorder.
Expert review of neurotherapeutics 2006;6(7):1039-48.
2006: Rainer Marco Kaufmann; Daniel Schreinzer; Alexandra Strnad; Nilufar Mossaheb; Siegfried Kasper; Richard Frey
Case report: intestinal atonia as an unusual symptom of malignant catatonia responsive to electroconvulsive therapy.
Schizophrenia research 2006;84(1):178-9.
2006: Dietmar Winkler; Edda Pjrek; Anastasios Konstantinidis; Nicole Praschak-Rieder; Matthäus Willeit; Jürgen Stastny; Siegfried Kasper
Anger attacks in seasonal affective disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(2):215-9.
2006: Siegfried Kasper; Christian Spadone; Patrice Verpillat; Jules Angst
Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis.
International clinical psychopharmacology 2006;21(2):105-10.
2006: Siegfried Kasper; Amanda J Lowry; Andrew Hodge; István Bitter; Martin Dossenbach
Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America.
Schizophrenia research 2006;81(2-3):139-43.
2006: Siegfried Kasper; Ole Michael Lemming; Hans de Swart
Escitalopram in the long-term treatment of major depressive disorder in elderly patients.
Neuropsychobiology 2006;54(3):152-9.
2006: Siegfried Kasper; Ion Anghelescu; Armin Szegedi; Angelika Dienel; Meinhard Kieser
Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
BMC medicine 2006;4():14.
2006: Dietmar Winkler; Edda Pjrek; Jochen Kindler; Angela Heiden; Siegfried Kasper
Validation of a simplified definition of anger attacks.
Psychotherapy and psychosomatics 2006;75(2):103-6.
2006: Nilufar Mossaheb; G Wiesegger; G Paul Amminger; Siegfried Kasper; Johannes Tauscher
[Early recognition and intervention for schizophrenia].
Der Nervenarzt 2006;77(1):23-4, 27-30, 32-4.
2005: Nicole Praschak-Rieder; Matthäus Willeit; Peter Zill; Dietmar Winkler; Nikolaus Thierry; Anastasios Konstantinidis; Mario Masellis; Vincenzo S Basile; Brigitta Bondy; Manfred Ackenheil; Alexander Neumeister; Allan S Kaplan; James L Kennedy; Siegfried Kasper; Robert D Levitan
A Cys 23-Ser 23 substitution in the 5-HT(2C) receptor gene influences body weight regulation in females with seasonal affective disorder: an Austrian-Canadian collaborative study.
Journal of psychiatric research 2005;39(6):561-7.
2005: Siegfried Kasper; Hans de Swart; Henning Friis Andersen
Escitalopram in the treatment of depressed elderly patients.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(10):884-91.
2005: Dietmar Winkler; Edda Pjrek; Nicole Praschak-Rieder; Matthäus Willeit; Lukas Pezawas; Anastasios Konstantinidis; Jürgen Stastny; Siegfried Kasper
Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy.
Biological psychiatry 2005;58(4):331-6.
2005: Siegfried Kasper; L Olivieri; G Di Loreto; Paolo Dionisio
A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder.
Current medical research and opinion 2005;21(8):1139-46.
2005: Edda Pjrek; Dietmar Winkler; Siegfried Kasper
Pharmacotherapy of seasonal affective disorder.
CNS spectrums 2005;10(8):664-9; quiz 672.
2005: Siegfried Kasper
Is SAD Lost to SAD?
CNS spectrums 2005;10(8):622.
2005: Angela Naderi-Heiden; Richard Frey; Otto Presslich; Patrick Frottier; Ulrike Willinger; Thomas Blasbichler; Ronald Smetana; Daniela Schmid; Siegfried Kasper
Effect of intravenous magnesium sulphate in reducing irritability and restlessness in pure and polysubstance opiate detoxification.
Psychiatry research 2005;135(1):53-63.
2005: Angela Heiden; Joachim Kettenbach; Peter Fischer; Bettina Schein; Ahmed Ba-Ssalamah; Richard Frey; Mohammad Mehdi Naderi; Talin Gulesserian; Daniela Schmid; Siegfried Trattnig; Herwig Imhof; Siegfried Kasper
White matter hyperintensities and chronicity of depression.
Journal of psychiatric research 2005;39(3):285-93.
2005: Siegfried Kasper; Dan Stein; Henrik Loft; Rico Nil
Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study.
The British journal of psychiatry : the journal of mental science 2005;186():222-6.
2005: Lukas Pezawas; Jules Angst; Siegfried Kasper
Recurrent brief depression revisited.
International review of psychiatry (Abingdon, England) 2005;17(1):63-70.
2005: Dietmar Winkler; Edda Pjrek; Siegfried Kasper
Anger attacks in depression--evidence for a male depressive syndrome.
Psychotherapy and psychosomatics 2005;74(5):303-7.
2005: Michael K Rainer; Hermann A M Mucke; Andreas J Masching; Manfred Haushofer; Martin Karger; Siegfried Kasper; Alexander Kurz
[State of the art management of BPSD in dementia].
Psychiatrische Praxis 2005;32(1):31-8.
2005: Ursula Bailer; Georg Wiesegger; Franz Leisch; Karoline Fuchs; I Leitner; Martin Letmaier; Anastasios Konstantinidis; Jürgen Stastny; Werner Sieghart; Kurt Hornik; B Mitterauer; Siegfried Kasper; Harald N Aschauer
No association of clock gene T3111C polymorphism and affective disorders.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(1):51-5.
2004: Hans Rittmannsberger; Norman Sartorius; Mihaela Brad; Victoria Burtea; Nora Capraru; Pavel Cernak; Mojca Dernovçek; Ionescu Dobrin; Rosa Frater; Jozef Hasto; Mieta Hategan; Manfred Haushofer; J Kafka; Siegfried Kasper; Rodica Macrea; Ludvik Nabelek; Peter Nawka; Vladimir Novotny; Thomas Platz; Adela Pojar; Christoph Silberbauer; Sandor Fekete; Johannes Wancata; Elmar Windhager; Hans-Georg Zapotoczky; Robert Zöchling
Changing aspects of psychiatric inpatient treatment. A census investigation in five European countries.
European psychiatry : the journal of the Association of European Psychiatrists 2004;19(8):483-8.
2004: Nikolas Klein; Julia Sacher; Helene Wallner; Johannes Tauscher; Siegfried Kasper
Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics.
CNS spectrums 2004;9(11):823-32.
2004: Edda Pjrek; Dietmar Winkler; Angela Heiden; Nicole Praschak-Rieder; Matthäus Willeit; Anastasios Konstantinidis; Jürgen Stastny; Siegfried Kasper
Seasonality of birth in seasonal affective disorder.
The Journal of clinical psychiatry 2004;65(10):1389-93.
2004: Stuart A Montgomery; Yves Lecrubier; David S Baldwin; Siegfried Kasper; Malcolm Lader; Rico Nil; D Stein; J M Van Ree
ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2004;14(5):425-33.
2004: Siegfried Kasper; Martin Brecher; Lesley Fitton; Andrew Martin Jones
Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia.
International clinical psychopharmacology 2004;19(5):281-9.
2004: Dietmar Winkler; Edda Pjrek; Angela Heiden; Georg Wiesegger; Nikolas Klein; Anastasios Konstantinidis; Siegfried Kasper
Gender differences in the psychopathology of depressed inpatients.
European archives of psychiatry and clinical neuroscience 2004;254(4):209-14.
2004: Edda Pjrek; Dietmar Winkler; Jürgen Stastny; Anastasios Konstantinidis; Angela Heiden; Siegfried Kasper
Bright light therapy in seasonal affective disorder--does it suffice?
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2004;14(4):347-51.
2004: A de Mendelssohn; Siegfried Kasper; Johannes Tauscher
[Neuroimaging in substance abuse disorders].
Der Nervenarzt 2004;75(7):651-62.
2004: Edda Pjrek; Dietmar Winkler; Matthäus Willeit; Anastasios Konstantinidis; Nikolaus Thierry; Siegfried Kasper
Menstrual disturbances a rare side-effect of bright-light therapy.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004;7(2):239-40.
2004: Ursula Bailer; Martina de Zwaan; Franz Leisch; Alexandra Strnad; Claudia Lennkh-Wolfsberg; Nadia El-Giamal; Kurt Hornik; Siegfried Kasper
Guided self-help versus cognitive-behavioral group therapy in the treatment of bulimia nervosa.
The International journal of eating disorders 2004;35(4):522-37.
2004: Alexandra Schosser; Karoline Fuchs; Franz Leisch; Ursula Bailer; Kurt Meszaros; Elisabeth Lenzinger; Ulrike Willinger; Rainer Strobl; Angela Heiden; Christian Gebhardt; Siegfried Kasper; Werner Sieghart; Kurt Hornik; Harald N Aschauer
Possible linkage of schizophrenia and bipolar affective disorder to chromosome 3q29; a follow-up.
Journal of psychiatric research 2004;38(3):357-64.
2004: Martin Letmaier; Daniel Schreinzer; Nikolaus Thierry; Rainer Wolf; Siegfried Kasper
[Drug therapy of acute manias. A retrospective data analysis of inpatients from 1997 to 1999].
Der Nervenarzt 2004;75(3):249-57.
2004: Dan Stein; Siegfried Kasper; Elisabeth Wreford Andersen; Rico Nil; Malcolm Lader
Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions.
Depression and anxiety 2004;20(4):175-81.
2004: Siegfried Kasper
Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia.
Depression and anxiety 2004;20(1):44-7.
2004: Siegfried Kasper; Angelika Dienel; Meinhard Kieser
Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after successful acute treatment of mild to moderate depression--rationale and study design.
International journal of methods in psychiatric research 2004;13(3):176-83.
2004: Nikolaus Thierry; Matthäus Willeit; Nicole Praschak-Rieder; Peter Zill; Kurt Hornik; Alexander Neumeister; Elisabeth Lenzinger; Jürgen Stastny; Eva Hilger; Anastasios Konstantinidis; Harald N Aschauer; Manfred Ackenheil; Brigitta Bondy; Siegfried Kasper
Serotonin transporter promoter gene polymorphic region (5-HTTLPR) and personality in female patients with seasonal affective disorder and in healthy controls.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2004;14(1):53-8.
2003: Siegfried Kasper; Mark N Lerman; Robert D McQuade; Anutosh Saha; William H Carson; Mirza Ali; Donald Archibald; Gary G Ingenito; Ronald Marcus; Teresa A Pigott
Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2003;6(4):325-37.
2003: Matthäus Willeit; Nicole Praschak-Rieder; Alexander Neumeister; Peter Zill; Franz Leisch; Jürgen Stastny; Eva Hilger; Nikolaus Thierry; Anastasios Konstantinidis; Dietmar Winkler; Karoline Fuchs; Werner Sieghart; Harald N Aschauer; Manfred Ackenheil; Brigitta Bondy; Siegfried Kasper
A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder.
Molecular psychiatry 2003;8(11):942-6.
2003: Matthäus Willeit; Nicole Praschak-Rieder; Peter Zill; Alexander Neumeister; Manfred Ackenheil; Siegfried Kasper; Brigitta Bondy
C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder.
Biological psychiatry 2003;54(7):682-6.
2003: Siegfried Kasper
Issues in the treatment of bipolar disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2003;13 Suppl 2():S37-42.
2003: Stephan Gruber; Richard Frey; Vladimír Mlynárik; Andreas Stadlbauer; Angela Heiden; Siegfried Kasper; Graham Kemp; Ewald Moser
Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla.
Investigative radiology 2003;38(7):403-8.
2003: Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
[Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease].
Wiener klinische Wochenschrift 2003;115(9):281-90.
2003: Lukas Pezawas; H U Wittchen; H Pfister; Jules Angst; R Lieb; Siegfried Kasper
Recurrent brief depressive disorder reinvestigated: a community sample of adolescents and young adults.
Psychological medicine 2003;33(3):407-18.
2003: Dietmar Winkler; Matthäus Willeit; Rainer Wolf; Mara Stamenkovic; Johannes Tauscher; Edda Pjrek; Anastasios Konstantinidis; Shird Schindler; Christian Barnas; Siegfried Kasper
Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2003;13(2):129-34.
2003: Nadia El-Giamal; Martina de Zwaan; Ursula Bailer; Alexandra Strnad; Petra Schüssler; Siegfried Kasper
Milnacipran in the treatment of bulimia nervosa: a report of 16 cases.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2003;13(2):73-9.
2003: Jürgen Stastny; Anastasios Konstantinidis; Markus Schwarz; Norman Rosenthal; Oliver Vitouch; Siegfried Kasper; Alexander Neumeister
Effects of tryptophan depletion and catecholamine depletion on immune parameters in patients with seasonal affective disorder in remission with light therapy.
Biological psychiatry 2003;53(4):332-7.
2003: Dietmar Winkler; Edda Pjrek; Lukas Pezawas; Otto Presslich; Johannes Tauscher; Siegfried Kasper
Relationship between power spectra of the awake EEG and psychomotor activity patterns measured by short-term actigraphy.
Neuropsychobiology 2003;48(4):176-81.
2003: Eva Hilger; Christian Barnas; Siegfried Kasper
Quetiapine in the treatment of borderline personality disorder.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2003;4(1):42-4.
2003: Siegfried Kasper; E Resinger
Cognitive effects and antipsychotic treatment.
Psychoneuroendocrinology 2003;28 Suppl 1():27-38.
2002: Siegfried Kasper
Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
International clinical psychopharmacology 2002;17 Suppl 4():S19-26.
2002: Siegfried Kasper; A Dienel
Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials.
Psychopharmacology 2002;164(3):301-8.
2002: Shird Schindler; André Graf; Peter Fischer; Anton Tölk; Siegfried Kasper
Paranoid delusions and hallucinations and bright light therapy in Alzheimer's disease.
International journal of geriatric psychiatry 2002;17(11):1071-2.
2002: Lukas Pezawas; Mara Stamenkovic; Reinhold Jagsch; Sandra Ackerl; Christine Putz; Barbara Stelzer; Rebecca R Moffat; Shird Schindler; Harald N Aschauer; Siegfried Kasper
A longitudinal view of triggers and thresholds of suicidal behavior in depression.
The Journal of clinical psychiatry 2002;63(10):866-73.
2002: Franz Riederer; Mara Stamenkovic; Shird Schindler; Siegfried Kasper
[Tourette's syndrome - a review].
Der Nervenarzt 2002;73(9):805-19.
2002: Siegfried Kasper; Mara Stamenkovic; Martin Letmaier; Daniel Schreinzer
Atypical antipsychotics in mood disorders.
International clinical psychopharmacology 2002;17 Suppl 3():S1-10.
2002: Siegfried Kasper; J P Olié
A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression.
European psychiatry : the journal of the Association of European Psychiatrists 2002;17 Suppl 3():331-40.
2002: Siegfried Kasper; Johannes Tauscher; Matthäus Willeit; Mara Stamenkovic; Alexander Neumeister; Bernd Küfferle; Christian Barnas; Jürgen Stastny; Nicole Praschak-Rieder; Lukas Pezawas; Martina de Zwaan; Sylvia Quiner; Walter Pirker; Susanne Asenbaum; Ivo Podreka; Thomas Brücke
Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(3):133-46.
2002: Dietmar Winkler; Nicole Praschak-Rieder; Matthäus Willeit; M J Lucht; Eva Hilger; Anastasios Konstantinidis; Jürgen Stastny; Nikolaus Thierry; Edda Pjrek; Alexander Neumeister; Hans-Jürgen Möller; Siegfried Kasper
[Seasonal affective depression in 2 German speaking university centers: Bonn, Vienna. Clinical and demographic characteristics].
Der Nervenarzt 2002;73(7):637-43.
2002: Richard Frey; Daniel Schreinzer; Th Stimpfl; Walter Vycudilik; A Berzlanovich; Siegfried Kasper
[Fatal poisonings with antidepressive drugs and neuroleptics. Analysis of a correlation with prescriptions in Vienna 1991 to 1997].
Der Nervenarzt 2002;73(7):629-36.
2002: Alexander Neumeister; Anastasios Konstantinidis; Jürgen Stastny; Markus Schwarz; Oliver Vitouch; Matthäus Willeit; Nicole Praschak-Rieder; Johanna Zach; Martina de Zwaan; Brigitta Bondy; Manfred Ackenheil; Siegfried Kasper
Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression.
Archives of general psychiatry 2002;59(7):613-20.
2002: Ursula Bailer; Franz Leisch; Kurt Meszaros; Elisabeth Lenzinger; Ulrike Willinger; Rainer Strobl; Angela Heiden; Christian Gebhardt; Elisabeth Döge; Karoline Fuchs; Werner Sieghart; Siegfried Kasper; Kurt Hornik; Harald N Aschauer
Genome scan for susceptibility loci for schizophrenia and bipolar disorder.
Biological psychiatry 2002;52(1):40-52.
2002: Siegfried Kasper; F Müller-Spahn
Intravenous antidepressant treatment: focus on citalopram.
European archives of psychiatry and clinical neuroscience 2002;252(3):105-9.
2002: Johannes Tauscher; Bernd Küfferle; Susanne Asenbaum; Sitra Tauscher-Wisniewski; Siegfried Kasper
Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.
Psychopharmacology 2002;162(1):42-9.
2002: Johannes Tauscher; Shitij Kapur; Nicolaas P L G Verhoeff; Doug F Hussey; Zafiris J Daskalakis; Sitra Tauscher-Wisniewski; Alan Wilson; Sylvain Houle; Siegfried Kasper; Robert B Zipursky
Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.
Archives of general psychiatry 2002;59(6):514-20.
2002: Dietmar Winkler; Matthäus Willeit; Nicole Praschak-Rieder; M J Lucht; Eva Hilger; Anastasios Konstantinidis; Jürgen Stastny; Nikolaus Thierry; Edda Pjrek; Alexander Neumeister; Hans-Jürgen Möller; Siegfried Kasper
Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample.
European archives of psychiatry and clinical neuroscience 2002;252(2):54-62.
2002: Nicole Praschak-Rieder; Matthäus Willeit; Dietmar Winkler; Alexander Neumeister; Eva Hilger; Peter Zill; Kurt Hornik; Jürgen Stastny; Nikolaus Thierry; Manfred Ackenheil; Brigitta Bondy; Siegfried Kasper
Role of family history and 5-HTTLPR polymorphism in female seasonal affective disorder patients with and without premenstrual dysphoric disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2002;12(2):129-34.
2002: Siegfried Kasper; Rainer Wolf
Successful treatment of reboxetine-induced urinary hesitancy with tamsulosin.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2002;12(2):119-22.
2002: Sylvia Quiner; Martin Letmaier; Christian Barnas; Angela Heiden; Siegfried Kasper
[Transcranial magnetic stimulation (TMS)--from diagnostic procedure to therapy].
Wiener klinische Wochenschrift 2002;114(5-6):181-6.
2002: Lukas Pezawas; Mara Stamenkovic; N Aschauer; R Moffat; Siegfried Kasper
Successful treatment of recurrent brief depression with reboxetine -- a single case analysis.
Pharmacopsychiatry 2002;35(2):75-6.
2002: Siegfried Kasper
Managing reboxetine-associated urinary hesitancy in a patient with major depressive disorder: a case study.
Psychopharmacology 2002;159(4):445-6.
2002: Anastasios Konstantinidis; Jürgen Stastny; J Ptak-Butta; Eva Hilger; Dietmar Winkler; Christian Barnas; Alexander Neumeister; Siegfried Kasper
Intravenous mirtazapine in the treatment of depressed inpatients.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2002;12(1):57-60.
2002: Eva Hilger; Nicole Praschak-Rieder; Matthäus Willeit; Jürgen Stastny; A Konstandinidis; Alexander Neumeister; Siegfried Kasper
[Pharmacotherapy of seasonal depression].
Der Nervenarzt 2002;73(1):22-9; quiz 30-1.
2002: Lukas Pezawas; Gabriele Fischer; Ivo Podreka; Shird Schindler; Thomas Brücke; Reinhold Jagsch; Maida Thurnher; Siegfried Kasper
Opioid addiction changes cerebral blood flow symmetry.
Neuropsychobiology 2002;45(2):67-73.
2001: Alexander Neumeister; Anastasios Konstantinidis; Nicole Praschak-Rieder; Matthäus Willeit; Eva Hilger; Jürgen Stastny; Siegfried Kasper
Monoaminergic function in the pathogenesis of seasonal affective disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2001;4(4):409-20.
2001: Alexander Neumeister; Matthäus Willeit; Nicole Praschak-Rieder; Susanne Asenbaum; Jürgen Stastny; Eva Hilger; Walter Pirker; Anastasios Konstantinidis; Siegfried Kasper
Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls.
Psychological medicine 2001;31(8):1467-73.
2001: André Graf; C Wallner; V Schubert; Matthäus Willeit; W Wlk; Peter Fischer; Siegfried Kasper; Alexander Neumeister
The effects of light therapy on mini-mental state examination scores in demented patients.
Biological psychiatry 2001;50(9):725-7.
2001: Siegfried Kasper; Johannes Tauscher; Angela Heiden
Quetiapine: efficacy and tolerability in schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11 Suppl 4():S405-13.
2001: Christian Barnas; Sylvia Quiner; Johannes Tauscher; Eva Hilger; Matthäus Willeit; Bernd Küfferle; Susanne Asenbaum; Thomas Brücke; M L Rao; Siegfried Kasper
In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients.
Psychopharmacology 2001;157(3):236-42.
2001: Richard Frey; Daniel Schreinzer; Angela Heiden; Siegfried Kasper
[Use of electroconvulsive therapy in psychiatry].
Der Nervenarzt 2001;72(9):661-76.
2001: Martin Letmaier; Daniel Schreinzer; Rainer Wolf; Siegfried Kasper
Topiramate as a mood stabilizer.
International clinical psychopharmacology 2001;16(5):295-8.
2001: Siegfried Kasper; E Resinger
Efficacy of noradrenergic-selective agents in the treatment of neuropsychiatric diseases.
CNS spectrums 2001;6(8):710-3.
2001: Siegfried Kasper; E Resinger
Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(4):307-21.
2001: Johannes Tauscher; R M Bagby; M Javanmard; Bruce K Christensen; Siegfried Kasper; Shitij Kapur
Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: a [(11)C]WAY-100635 PET investigation in healthy volunteers.
The American journal of psychiatry 2001;158(8):1326-8.
2001: Siegfried Kasper
Hypericum perforatum--a review of clinical studies.
Pharmacopsychiatry 2001;34 Suppl 1():S51-5.
2001: Mara Stamenkovic; T Blasbichier; Franz Riederer; Lukas Pezawas; N Brandstätter; Harald N Aschauer; Siegfried Kasper
Fluoxetine treatment in patients with recurrent brief depression.
International clinical psychopharmacology 2001;16(4):221-6.
2001: Siegfried Kasper; M Jones; I Duchesne
Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): health economic results of an international naturalistic study.
International clinical psychopharmacology 2001;16(4):189-96.
2001: Siegfried Kasper; D Rosillon; I Duchesne
Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study.
International clinical psychopharmacology 2001;16(4):179-87.
2001: Matthäus Willeit; Jürgen Stastny; Walter Pirker; Nicole Praschak-Rieder; Alexander Neumeister; Susanne Asenbaum; Johannes Tauscher; Karoline Fuchs; Werner Sieghart; Kurt Hornik; Harald N Aschauer; Thomas Brücke; Siegfried Kasper
No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism.
Biological psychiatry 2001;50(1):8-12.
2001: Richard Frey; Angela Heiden; Joachim Scharfetter; Daniel Schreinzer; Thomas Blasbichler; Johannes Tauscher; Peter Felleiter; Siegfried Kasper
Inverse relation between stimulus intensity and seizure duration: implications for ECT procedure.
The journal of ECT 2001;17(2):102-8.
2001: Siegfried Kasper; Sylvia Quiner; Christian Barnas; H Fabisch; Manfred Haushofer; C Sackel; P König; A Lingg; Thomas Platz; Hans Rittmannsberger; C Stuppäck; Matthäus Willeit; Hans-Georg Zapotoczky
Zotepine in the treatment of acute hospitalized schizophrenic episodes.
International clinical psychopharmacology 2001;16(3):163-8.
2001: Daniel Schreinzer; Richard Frey; Th Stimpfl; Walter Vycudilik; A Berzlanovich; Siegfried Kasper
Different fatal toxicity of neuroleptics identified by autopsy.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(2):117-24.
2001: Lukas Pezawas; Mara Stamenkovic; Siegfried Kasper
[Recurrent brief depressive episodes. Epidemiology, clinical aspects, diagnosis and therapy].
Der Nervenarzt 2001;72(3):169-80.
2001: Nicole Praschak-Rieder; Matthäus Willeit; Alexander Neumeister; Eva Hilger; Jürgen Stastny; Nikolaus Thierry; Elisabeth Lenzinger; Siegfried Kasper
Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder.
Journal of affective disorders 2001;63(1-3):239-42.
2001: Johannes Tauscher; Walter Pirker; Matthäus Willeit; Martina de Zwaan; Ursula Bailer; Alexander Neumeister; Susanne Asenbaum; C Lennkh; Nicole Praschak-Rieder; Thomas Brücke; Siegfried Kasper
[123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa.
Biological psychiatry 2001;49(4):326-32.
2001: Mara Stamenkovic; Shird Schindler; Susanne Asenbaum; Alexander Neumeister; Matthäus Willeit; Ulrike Willinger; Martina de Zwaan; Franz Riederer; Harald N Aschauer; Siegfried Kasper
No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(1):69-74.
2001: Eva Hilger; Matthäus Willeit; Nicole Praschak-Rieder; Jürgen Stastny; Alexander Neumeister; Siegfried Kasper
Reboxetine in seasonal affective disorder: an open trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(1):1-5.
2001: Mara Stamenkovic; Harald N Aschauer; Franz Riederer; Shird Schindler; Franz Leisch; E Resinger; Alexander Neumeister; Kurt Hornik; Siegfried Kasper
Study of family history in seasonal affective disorder.
Neuropsychobiology 2001;44(2):65-9.
2000: Eva Hilger; Siegfried Kasper
[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Wiener klinische Wochenschrift 2000;112(24):1031-8.
2000: Siegfried Kasper; V Schulz
[St. Johns wort extract as plant antidepressant].
Praxis 2000;89(51-52):2169-77.
2000: Wolfgang Gombas; Gabriele Fischer; Reinhold Jagsch; Harald Eder; I Okamoto; Shird Schindler; C Müller; P Ferenci; Siegfried Kasper
Prevalence and distribution of hepatitis C subtypes in patients with opioid dependence.
European addiction research 2000;6(4):198-204.
2000: Nadia El-Giamal; Martina de Zwaan; Ursula Bailer; C Lennkh; Petra Schüssler; Alexandra Strnad; Siegfried Kasper
Reboxetine in the treatment of bulimia nervosa: a report of seven cases.
International clinical psychopharmacology 2000;15(6):351-6.
2000: Kurt Meszaros; Elisabeth Lenzinger; Kurt Hornik; T Füreder; Thomas Stompe; Ulrike Willinger; Angela Heiden; Nahid Fathi; E Gerhard; Karoline Fuchs; Werner Sieghart; Siegfried Kasper; Harald N Aschauer
Association study of schizophrenia spectrum disorders and dopamine D3 receptor gene: is schizoaffective disorder special?
Psychiatry research 2000;96(2):179-83.
2000: Ursula Bailer; Martina de Zwaan; Petra Schüssler; Nadia El-Giamal; Alexandra Strnad; C Lennkh; Siegfried Kasper
[Diagnosis and therapy of eating disorders].
Wiener klinische Wochenschrift 2000;112(20):865-75.
2000: Johannes Tauscher; Sitra Tauscher-Wisniewski; Siegfried Kasper
Treatment of patients with delirium.
The American journal of psychiatry 2000;157(10):1711.
2000: Christian Gebhardt; Franz Leisch; Petra Schüssler; Karoline Fuchs; Thomas Stompe; Werner Sieghart; Kurt Hornik; Siegfried Kasper; Harald N Aschauer
Non-association of dopamine D4 and D2 receptor genes with personality in healthy individuals.
Psychiatric genetics 2000;10(3):131-7.
2000: Ursula Bailer; P Fischer; Bernd Küfferle; Jürgen Stastny; Siegfried Kasper
Occurrence of mirtazapine-induced delirium in organic brain disorder.
International clinical psychopharmacology 2000;15(4):239-43.
2000: Lukas Pezawas; Sylvia Quiner; Deddo Moertl; Johannes Tauscher; Christian Barnas; Bernd Küfferle; Rainer Wolf; Siegfried Kasper
Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance.
International clinical psychopharmacology 2000;15(4):207-14.
2000: Siegfried Kasper; F Müller-Spahn
Review of quetiapine and its clinical applications in schizophrenia.
Expert opinion on pharmacotherapy 2000;1(4):783-801.
2000: Siegfried Kasper; Nadia El-Giamal; Eva Hilger
Reboxetine: the first selective noradrenaline re-uptake inhibitor.
Expert opinion on pharmacotherapy 2000;1(4):771-82.
2000: Matthäus Willeit; Nicole Praschak-Rieder; Alexander Neumeister; Walter Pirker; Susanne Asenbaum; Oliver Vitouch; Johannes Tauscher; Eva Hilger; Jürgen Stastny; Thomas Brücke; Siegfried Kasper
[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.
Biological psychiatry 2000;47(6):482-9.
2000: Richard Frey; Daniel Schreinzer; Th Stimpfl; Walter Vycudilik; A Berzlanovich; Siegfried Kasper
Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991-1997: the favourable consequences of the increasing use of SSRIs.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2000;10(2):133-42.
2000: Alexander Neumeister; Walter Pirker; Matthäus Willeit; Nicole Praschak-Rieder; Susanne Asenbaum; Thomas Brücke; Siegfried Kasper
Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.
Biological psychiatry 2000;47(2):158-60.
2000: Ursula Bailer; Franz Leisch; Kurt Meszaros; Elisabeth Lenzinger; Ulrike Willinger; Rainer Strobl; Christian Gebhardt; E Gerhard; Karoline Fuchs; Werner Sieghart; Siegfried Kasper; Kurt Hornik; Harald N Aschauer
Genome scan for susceptibility loci for schizophrenia.
Neuropsychobiology 2000;42(4):175-82.
2000: Angela Heiden; Petra Schüssler; U Itzlinger; Franz Leisch; Joachim Scharfetter; Christian Gebhardt; Karoline Fuchs; Matthäus Willeit; L Nilsson; E Miller-Reiter; Thomas Stompe; Kurt Meszaros; Werner Sieghart; Kurt Hornik; Siegfried Kasper; Harald N Aschauer
Association studies of candidate genes in bipolar disorders.
Neuropsychobiology 2000;42 Suppl 1():18-21.
2000: C Vesely; Bernd Küfferle; Thomas Brücke; Siegfried Kasper
Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine.
International clinical psychopharmacology 2000;15(1):57-60.
2000: Mara Stamenkovic; Shird Schindler; Harald N Aschauer; Martina de Zwaan; Ulrike Willinger; E Resinger; Siegfried Kasper
Effective open-label treatment of tourette's disorder with olanzapine.
International clinical psychopharmacology 2000;15(1):23-8.
1999: Angela Heiden; Richard Frey; Otto Presslich; Thomas Blasbichler; R Smetana; Siegfried Kasper
Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy.
Psychiatry research 1999;89(3):239-46.
1999: Joachim Scharfetter; H R Chaudhry; Kurt Hornik; Karoline Fuchs; Werner Sieghart; Siegfried Kasper; Harald N Aschauer
Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;10(1):17-20.
1999: T Kapitany; M Schindl; Shird Schindler; B Hesselmann; T Füreder; Christian Barnas; Werner Sieghart; Siegfried Kasper
The citalopram challenge test in patients with major depression and in healthy controls.
Psychiatry research 1999;88(2):75-88.
1999: Martha Feucht; Karoline Fuchs; E Pichlbauer; Kurt Hornik; Joachim Scharfetter; R Goessler; T Füreder; N Cvetkovic; Werner Sieghart; Siegfried Kasper; Harald N Aschauer
Possible association between childhood absence epilepsy and the gene encoding GABRB3.
Biological psychiatry 1999;46(7):997-1002.
1999: Gabriele Fischer; Wolfgang Gombas; Harald Eder; Reinhold Jagsch; Alexandra Peternell; G Stühlinger; Lukas Pezawas; Harald N Aschauer; Siegfried Kasper
Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
Addiction (Abingdon, England) 1999;94(9):1337-47.
1999: Alexander Neumeister; A Habeler; Nicole Praschak-Rieder; Matthäus Willeit; Siegfried Kasper
Tryptophan depletion: a predictor of future depressive episodes in seasonal affective disorder?
International clinical psychopharmacology 1999;14(5):313-5.
1999: C Lennkh; Martina de Zwaan; Ursula Bailer; Alexandra Strnad; C Nagy; Nadia El-Giamal; E Vytiska; Siegfried Kasper
[Osteoporosis in anorexia nervosa. New aspects of pathogenesis and therapy].
Der Nervenarzt 1999;70(9):823-9.
1999: Gabriele Fischer; Wolfgang Gombas; Harald Eder; Reinhold Jagsch; G Stühlinger; Harald N Aschauer; Siegfried Kasper
[Buprenorphine vs. methadone as maintenance treatment for opioid dependence].
Der Nervenarzt 1999;70(9):795-802.
1999: C Lennkh; Martina de Zwaan; Ursula Bailer; Alexandra Strnad; C Nagy; Nadia El-Giamal; S Wiesnagrotzki; E Vytiska; J Huber; Siegfried Kasper
Osteopenia in anorexia nervosa: specific mechanisms of bone loss.
Journal of psychiatric research 1999;33(4):349-56.
1999: Siegfried Kasper
From symptoms to social functioning: differential effects of antidepressant therapy.
International clinical psychopharmacology 1999;14 Suppl 1():S27-31.
1999: Elisabeth Lenzinger; Alexander Neumeister; Nicole Praschak-Rieder; Karoline Fuchs; E Gerhard; Matthäus Willeit; Werner Sieghart; Siegfried Kasper; Kurt Hornik; Harald N Aschauer
Behavioral effects of tryptophan depletion in seasonal affective disorder associated with the serotonin transporter gene?
Psychiatry research 1999;85(3):241-6.
1999: Angela Heiden; Ulrike Willinger; Joachim Scharfetter; Kurt Meszaros; Siegfried Kasper; Harald N Aschauer
Anticipation in schizophrenia.
Schizophrenia research 1999;35(1):25-32.
1999: Alexander Neumeister; Nicole Praschak-Rieder; Matthäus Willeit; Jürgen Stastny; Siegfried Kasper
Monoamine depletion in non-pharmacological treatments for depression.
Advances in experimental medicine and biology 1999;467():29-33.
1999: Siegfried Kasper; Johannes Tauscher; Bernd Küfferle; Christian Barnas; Lukas Pezawas; Sylvia Quiner
Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 4():83-9.
1999: Siegfried Kasper
First-episode schizophrenia: the importance of early intervention and subjective tolerability.
The Journal of clinical psychiatry 1999;60 Suppl 23():5-9.
1999: Siegfried Kasper; A Hale; J M Azorin; Hans-Jürgen Möller
Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 2():II1-II14.
1999: Johannes Tauscher; Walter Pirker; Martina de Zwaan; Susanne Asenbaum; Thomas Brücke; Siegfried Kasper
In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;9(1-2):177-9.
1999: Johannes Tauscher; Bernd Küfferle; Susanne Asenbaum; P Fischer; Lukas Pezawas; Christian Barnas; Sitra Tauscher-Wisniewski; Thomas Brücke; Siegfried Kasper
In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
Psychopharmacology 1999;141(2):175-81.
1998: Siegfried Kasper
Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.
International clinical psychopharmacology 1998;13(6):253-62.
1998: Richard Frey; D Metzler; Peter Fischer; Angela Heiden; Joachim Scharfetter; Ewald Moser; Siegfried Kasper
Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla.
Journal of psychiatric research 1998;32(6):411-20.
1998: Ursula Bailer; Nicole Praschak-Rieder; Lukas Pezawas; Siegfried Kasper
[Mirtazapine in inpatient treatment of depressed patients].
Wiener klinische Wochenschrift 1998;110(18):646-50.
1998: Lukas Pezawas; Gabriele Fischer; K Diamant; C Schneider; Shird Schindler; M Thurnher; W Ploechl; Harald Eder; Siegfried Kasper
Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurements.
Psychiatry research 1998;83(3):139-47.
1998: Johannes Tauscher; Peter Fischer; Alexander Neumeister; Peter Rappelsberger; Siegfried Kasper
Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients.
Biological psychiatry 1998;44(6):438-47.
1998: Siegfried Kasper
Social phobia: the nature of the disorder.
Journal of affective disorders 1998;50 Suppl 1():S3-9.
1998: C Lennkh; P Fischer; Bernd Küfferle; Siegfried Kasper
Occurrence of trazodone-induced delirium.
International clinical psychopharmacology 1998;13(5):225-8.
1998: T Kapitany; Kurt Meszaros; Elisabeth Lenzinger; Shird Schindler; Christian Barnas; Karoline Fuchs; Werner Sieghart; Harald N Aschauer; Siegfried Kasper
Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia.
Schizophrenia research 1998;32(2):101-6.
1998: Angela Heiden; M de Zwaan; R Frey; Otto Presslich; Siegfried Kasper
Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
Journal of psychiatry & neuroscience : JPN 1998;23(3):179-80.
1998: Siegfried Kasper; Johannes Tauscher; Bernd Küfferle; Christian Barnas; B Hesselmann; Susanne Asenbaum; Ivo Podreka; Thomas Brücke
Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123I-IBZM SPECT study.
Psychopharmacology 1998;136(4):367-73.
1998: Siegfried Kasper
How much do novel antipsychotics benefit the patients?
International clinical psychopharmacology 1998;13 Suppl 3():S71-7.
1998: P Fischer; Johannes Tauscher; Bernd Küfferle; Siegfried Kasper
Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression.
International clinical psychopharmacology 1998;13(2):83-6.
1998: Alexander Neumeister; Nicole Praschak-Rieder; B Hesselmann; Oliver Vitouch; M Rauh; A Barocka; Siegfried Kasper
Effects of tryptophan depletion in fully remitted patients with seasonal affective disorder during summer.
Psychological medicine 1998;28(2):257-64.
1998: Alexander Neumeister; Nicole Praschak-Rieder; B Hesselmann; Oliver Vitouch; M Rauh; A Barocka; Johannes Tauscher; Siegfried Kasper
Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation.
Archives of general psychiatry 1998;55(2):167-72.
1998: Siegfried Kasper; Johannes Tauscher; E Küfferle; B Hesselmann; Christian Barnas; Thomas Brücke
IBZM-SPECT imaging of dopamine D(2) receptors with typical and atypical antipsychotics.
European psychiatry : the journal of the Association of European Psychiatrists 1998;13(1 Suppl 1):9s-14s.
1998: Siegfried Kasper; Johannes Tauscher; E Küfferle; B Hesselmann; Christian Barnas; Thomas Brücke
IBZM-SPECT imaging of dopamine D(2) receptors with typical and atypical antipsychotics.
European psychiatry : the journal of the Association of European Psychiatrists 1998;13 Suppl 1():9s-14s.
1998: Mara Stamenkovic; Lukas Pezawas; Martina de Zwaan; Harald N Aschauer; Siegfried Kasper
Mirtazapine in recurrent brief depression.
International clinical psychopharmacology 1998;13(1):39-40.
1998: Harald Eder; Gabriele Fischer; Wolfgang Gombas; Reinhold Jagsch; G Stühlinger; Siegfried Kasper
Comparison of buprenorphine and methadone maintenance in opiate addicts.
European addiction research 1998;4 Suppl 1():3-7.
1997: Bernd Küfferle; Johannes Tauscher; Susanne Asenbaum; C Vesely; Ivo Podreka; Thomas Brücke; Siegfried Kasper
IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.
Psychopharmacology 1997;133(4):323-8.
1997: Siegfried Kasper; Nicole Praschak-Rieder; Johannes Tauscher; R Wolf
A risk-benefit assessment of mirtazapine in the treatment of depression.
Drug safety : an international journal of medical toxicology and drug experience 1997;17(4):251-64.
1997: E Lenzinger; K Diamant; E Vytiska-Binstorfer; Siegfried Kasper
[Premenstrual dysphoric disorder. An overview of diagnosis, epidemiology and therapeutic approaches].
Der Nervenarzt 1997;68(9):708-18.
1997: Nicole Praschak-Rieder; Alexander Neumeister; B Hesselmann; Matthäus Willeit; Christian Barnas; Siegfried Kasper
Suicidal tendencies as a complication of light therapy for seasonal affective disorder: a report of three cases.
The Journal of clinical psychiatry 1997;58(9):389-92.
1997: Siegfried Kasper
Treatment of seasonal affective disorder (SAD) with hypericum extract.
Pharmacopsychiatry 1997;30 Suppl 2():89-93.
1997: Johannes Tauscher; Bernd Küfferle; Susanne Asenbaum; Thomas Brücke; Siegfried Kasper
Previous treatment as a confounding variable in studies with novel antipsychotics: two cases of high dopamine-2 receptor occupancy with quetiapine.
Psychopharmacology 1997;133(1):102-5.
1997: Alexander Neumeister; Nicole Praschak-Rieder; B Hesselmann; Oliver Vitouch; M Rauh; A Barocka; Siegfried Kasper
Rapid tryptophan depletion in drug-free depressed patients with seasonal affective disorder.
The American journal of psychiatry 1997;154(8):1153-5.
1997: Alexander Neumeister; Nicole Praschak-Rieder; B Hesselmann; Johannes Tauscher; Siegfried Kasper
[The tryptophan depletion test. Basic principles and clinical relevance].
Der Nervenarzt 1997;68(7):556-62.
1997: Johannes Tauscher; Alexander Neumeister; Peter Fischer; Richard Frey; Siegfried Kasper
[Electroconvulsive therapy in clinical practice].
Der Nervenarzt 1997;68(5):410-6.
1997: Siegfried Kasper; M Zivkov; K C Roes; A G Pols
Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1997;7(2):115-24.
1997: Siegfried Kasper
Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine.
Journal of clinical psychopharmacology 1997;17 Suppl 1():19S-28S.
1997: Siegfried Kasper; B Hesselmann; W Wein
[Maintenance therapy with 20 mg fluoxetine. Results of an administration study of 1,737 depressed patients].
Wiener klinische Wochenschrift 1997;109(6):197-201.
1997: Siegfried Kasper; Christian Barnas; Angela Heiden; H P Volz; G Laakmann; H Zeit; H Pfolz
Pramipexole as adjunct to haloperidol in schizophrenia. Safety and efficacy.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1997;7(1):65-70.
1997: Alexander Neumeister; Nicole Praschak-Rieder; B Besselmann; M L Rao; J Glück; Siegfried Kasper
Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy.
Archives of general psychiatry 1997;54(2):133-8.
1996: Bernd Küfferle; Thomas Brücke; A Topitz-Schratzberger; Johannes Tauscher; R Gössler; C Vesely; Susanne Asenbaum; Ivo Podreka; Siegfried Kasper
Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone.
Psychiatry research 1996;68(1):23-30.
1996: Edzard Klemm; Peter Danos; F Grünwald; Siegfried Kasper; Hans-Jürgen Möller; Hans-Jürgen Biersack
Temporal lobe dysfunction and correlation of regional cerebral blood flow abnormalities with psychopathology in schizophrenia and major depression--a study with single photon emission computed tomography.
Psychiatry research 1996;68(1):1-10.
1996: Siegfried Kasper; Y Pletan; A Solles; Alain Tournoux
Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
International clinical psychopharmacology 1996;11 Suppl 4():35-9.
1996: Marie Luise Rao; S Ruhrmann; B Retey; N Liappis; J Fuger; M Kraemer; Siegfried Kasper; Hans-Jürgen Möller
Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome.
Pharmacopsychiatry 1996;29(5):180-6.
1996: Siegfried Kasper; Shird Schindler; Alexander Neumeister
Risk of suicide in depression and its implication for psychopharmacological treatment.
International clinical psychopharmacology 1996;11(2):71-9.
1996: K Meszaros; Siegfried Kasper
[Psychopathological phenomena in long-term follow-up of acute psychosis after preventive mefloquinine (Lariam) administration].
Der Nervenarzt 1996;67(5):404-6.
1996: Metin Bagli; Marie Luise Rao; G Höflich; Siegfried Kasper; M Langer; U Barlage; M Beneke; Richard Süverkrüp; Hans-Jürgen Möller
Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.
Arzneimittel-Forschung 1996;46(3):247-50.
1996: M Stamenkovic; S Schindler; Siegfried Kasper
Poststroke depression and fluoxetine.
The American journal of psychiatry 1996;153(3):446-7.
1996: D A Oren; Alytia A Levendosky; Siegfried Kasper; C C Duncan; Norman Rosenthal
Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder.
Biological psychiatry 1996;39(3):157-70.
1996: Edzard Klemm; F Grünwald; Siegfried Kasper; Christian Menzel; K Broich; Peter Danos; Karl Reichmann; C Krappel; O Rieker; B Briele; A L Hotze; Hans-Jürgen Möller; Hans-Jürgen Biersack
[123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
The American journal of psychiatry 1996;153(2):183-90.
1996: C Schneider; Gabriele Fischer; K Diamant; R Hauk; Lukas Pezawas; E Lenzinger; Siegfried Kasper
[Pregnancy and drug dependence].
Wiener klinische Wochenschrift 1996;108(19):611-4.
1996: Kurt Meszaros; Elisabeth Lenzinger; T Füreder; Kurt Hornik; Ulrike Willinger; Thomas Stompe; Angela Heiden; E Resinger; N Fathi; E Gerhard; Karoline Fuchs; E Miller-Reiter; V Pfersmann; Werner Sieghart; Harald N Aschauer; Siegfried Kasper
Schizophrenia and the dopamine-beta-hydroxylase gene: results of a linkage and association study.
Psychiatric genetics 1996;6(1):17-22.
1996: Alexander Neumeister; R Goessler; M Lucht; T Kapitany; C Bamas; Siegfried Kasper
Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation.
Biological psychiatry 1996;39(1):16-21.
1996: M Stamenkovic; S Schindler; Siegfried Kasper
[Therapy of post-stroke depression with fluoxetine. A pilot project].
Der Nervenarzt 1996;67(1):62-7.
1995: Metin Bagli; G Höflich; Marie Luise Rao; M Langer; P Baumann; M Kolbinger; U Barlage; Siegfried Kasper; Hans-Jürgen Möller
Bioequivalence and absolute bioavailability of oblong and coated levomepromazine tablets in CYP2D6 phenotyped subjects.
International journal of clinical pharmacology and therapeutics 1995;33(12):646-52.
1995: Siegfried Kasper
Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.
International clinical psychopharmacology 1995;10 Suppl 4():25-35.
1995: Hans-Jürgen Möller; Siegfried Kasper; H Müller; Werner Kissling; J Fuger; S Ruhrmann
A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
Pharmacopsychiatry 1995;28(6):249-52.
1995: Siegfried Kasper; B Jung
[Psychiatrically relevant side effects of non-psychopharmacological pharmacotherapy].
Der Nervenarzt 1995;66(9):649-61.
1995: Shird Schindler; Christian Barnas; H Leitner; T Kapitany; Siegfried Kasper
Trigeminal neuralgic syndrome after bright light therapy.
The American journal of psychiatry 1995;152(8):1237.
1995: G Höflich; Siegfried Kasper; K W Burghof; H P Scholl; Hans-Jürgen Möller
Maintenance ECT for treatment of therapy-resistant paranoid schizophrenia and Parkinson's disease.
Biological psychiatry 1995;37(12):892-4.
1995: Johannes Tauscher; S Schindler; Peter Rappelsberger; Siegfried Kasper
[EEG changes in schizophrenic diseases--a critical review].
Fortschritte der Neurologie-Psychiatrie 1995;63(4):162-9.
1995: Walter Pirker; Susanne Asenbaum; Siegfried Kasper; H Walter; Peter Angelberger; G Koch; A Pozzera; Lüder Deecke; Ivo Podreka; Thomas Brücke
beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo.
Journal of neural transmission. General section 1995;100(3):247-56.
1995: Siegfried Kasper; Hans-Jürgen Möller; S A Montgomery; E Zondag
Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
International clinical psychopharmacology 1995;9 Suppl 4():3-12.
1994: Hans-Jürgen Möller; J Fuger; Siegfried Kasper
Efficacy of new generation antidepressants: meta-analysis of imipramine-controlled studies.
Pharmacopsychiatry 1994;27(6):215-23.
1994: B Martinez; Siegfried Kasper; S Ruhrmann; Hans-Jürgen Möller
Hypericum in the treatment of seasonal affective disorders.
Journal of geriatric psychiatry and neurology 1994;7 Suppl 1():S29-33.
1994: Siegfried Kasper; A Kasper
[Long-term treatment of affective disorders].
Der Nervenarzt 1994;65(9):577-89.
1994: T Kapitany; Siegfried Kasper
[Endocrine changes within the scope of psychiatric diseases].
Der Internist 1994;35(9):823-31.
1994: H P Scholl; Siegfried Kasper; Peter Danos; G Höflich; Hans-Jürgen Möller
[Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
Der Nervenarzt 1994;65(7):478-81.
1994: Peter Danos; Siegfried Kasper; H P Scholl; J Kaiser; S Ruhrmann; G Höflich; Hans-Jürgen Möller
Clinical response to sleep deprivation and auditory-evoked potentials--preliminary results.
Pharmacopsychiatry 1994;27(2):70-1.
1994: G Höflich; K W Burghof; Siegfried Kasper; Hans-Jürgen Möller
[Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease].
Der Nervenarzt 1994;65(3):202-5.
1994: Siegfried Kasper; S Ruhrmann; T Haase; Hans-Jürgen Möller
Evidence for a seasonal form of recurrent brief depression (RBD-seasonal).
European archives of psychiatry and clinical neuroscience 1994;244(4):205-10.
1994: Alexander Neumeister; T Kapitany; N Rieder; Siegfried Kasper
[Fall/winter depression and its therapy].
Wiener klinische Wochenschrift 1994;106(21):665-70.
1993: Christian Menzel; F Grünwald; Edzard Klemm; K Broich; Siegfried Kasper; Karl Reichmann; A L Hotze; Hans-Jürgen Biersack
[Brain SPECT with 123I-labelled iodobenzamide (IBZM): aspects of semiquantitative evaluation].
Nuklearmedizin. Nuclear medicine 1993;32(5):227-30.
1993: Siegfried Kasper; M Dötsch; H Kick; A Vieira; Hans-Jürgen Möller
Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1993;3(1):13-21.
1993: Siegfried Kasper
The rationale for long-term antidepressant therapy.
International clinical psychopharmacology 1993;8(4):225-35.
1992: G Höflich; Siegfried Kasper; Peter Danos; R Schmidt
Thyroid hormones, body temperature, and antidepressant treatment.
Biological psychiatry 1992;31(8):859-62.
1992: Siegfried Kasper; J Fuger; H J Zinner; J Bäuml; Hans-Jürgen Möller
Early clinical results with the neuroleptic roxindole (EMD 49,980) in the treatment of schizophrenia--an open study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1992;2(1):91-5.
1992: Siegfried Kasper; Thomas Wehr
The role of sleep and wakefulness in the genesis of depression and mania.
L'Encéphale 1992;18 Spec No 1():45-50.
1992: Siegfried Kasper; S Ruhrmann; T Haase; Hans-Jürgen Möller
Recurrent brief depression and its relationship to seasonal affective disorder.
European archives of psychiatry and clinical neuroscience 1992;242(1):20-6.
1992: Siegfried Kasper; J Fuger; Hans-Jürgen Möller
Comparative efficacy of antidepressants.
Drugs 1992;43 Suppl 2():11-22; discussion 22-3.
1991: Thomas Wehr; H A Giesen; P M Schulz; J L Anderson; J R Joseph-Vanderpool; K Kelly; Siegfried Kasper; Norman Rosenthal
Contrasts between symptoms of summer depression and winter depression.
Journal of affective disorders 1991;23(4):173-83.
1991: J R Joseph-Vanderpool; Norman Rosenthal; George Chrousos; Thomas Wehr; R Skwerer; Siegfried Kasper; Philip W Gold
Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications.
The Journal of clinical endocrinology and metabolism 1991;72(6):1382-7.
1991: Siegfried Kasper; H Kick; G Voll; A Vieira
Therapeutic sleep deprivation and antidepressant medication in patients with major depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1991;1(2):107-11.
1991: Siegfried Kasper; Norman Rosenthal; S Barberi; A Williams; L Tamarkin; S L Rogers; Stanley R Pillemer
Immunological correlates of seasonal fluctuations in mood and behavior and their relationship to phototherapy.
Psychiatry research 1991;36(3):253-64.
1991: TA Hardin; Thomas Wehr; Timothy D Brewerton; Siegfried Kasper; W Berrettini; J Rabkin; Norman Rosenthal
Evaluation of seasonality in six clinical populations and two normal populations.
Journal of psychiatric research 1991;25(3):75-87.
1990: Siegfried Kasper; T Kamo
Seasonality in major depressed inpatients.
Journal of affective disorders 1990;19(4):243-8.
1990: Siegfried Kasper; G Voll; A Vieira; H Kick
Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
Pharmacopsychiatry 1990;23(3):135-42.
1990: Siegfried Kasper; A Vieira; R Schmidt; P Richter
Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment.
Pharmacopsychiatry 1990;23(2):76-84.
1990: Siegfried Kasper; S L Rogers; P A Madden; J R Joseph-Vanderpool; Norman Rosenthal
The effects of phototherapy in the general population.
Journal of affective disorders 1990;18(3):211-9.
1990: Norman Rosenthal; Alytia A Levendosky; R G Skwerer; J R Joseph-Vanderpool; K A Kelly; T Hardin; Siegfried Kasper; P DellaBella; Thomas Wehr
Effects of light treatment on core body temperature in seasonal affective disorder.
Biological psychiatry 1990;27(1):39-50.
1989: Siegfried Kasper; Thomas Wehr; J J Bartko; PAUL GAIST; Norman Rosenthal
Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland.
Archives of general psychiatry 1989;46(9):823-33.
1989: Siegfried Kasper; S L Rogers; A Yancey; P M Schulz; R G Skwerer; Norman Rosenthal
Phototherapy in individuals with and without subsyndromal seasonal affective disorder.
Archives of general psychiatry 1989;46(9):837-44.
1989: J J Bartko; Siegfried Kasper
Seasonal changes in mood and behavior: a cluster analytic approach.
Psychiatry research 1989;28(2):227-39.
1989: E Souêtre; Norman Rosenthal; Siegfried Kasper; Thomas Wehr
[Effects of light in depressive syndromes].
Presse médicale (Paris, France : 1983) 1989;18(2):53-4.
1988: Siegfried Kasper; S L Rogers; A L Yancey; P M Schulz; R G Skwerer; Norman Rosenthal
Phototherapy in subsyndromal seasonal affective disorder (S-SAD) and "diagnosed" controls.
Pharmacopsychiatry 1988;21(6):428-9.
1988: Siegfried Kasper; David A Sack; Thomas Wehr; H Kick; G Voll; A Vieira
Nocturnal TSH and prolactin secretion during sleep deprivation and prediction of antidepressant response in patients with major depression.
Biological psychiatry 1988;24(6):631-41.
1988: Siegfried Kasper; A Vieira; Thomas Wehr; R Schmidt; H Kick; G Voll; D L Murphy
Serotonergically induced hormonal responses and the antidepressant effect of total sleep deprivation in patients with major depression.
Psychopharmacology bulletin 1988;24(3):450-3.
1988: R G Skwerer; F M Jacobsen; C C Duncan; K A Kelly; D A Sack; L Tamarkin; PAUL GAIST; Siegfried Kasper; Norman Rosenthal
Neurobiology of seasonal affective disorder and phototherapy.
Journal of biological rhythms 1988;3(2):135-54.